- Home
- LXEH vs KTTA Comparison
LXEH vs KTTA Comparison
Compare LXEH & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LXEH | KTTA |
|---|---|---|
| Founded | 2001 | 2020 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1M | 5.3M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LXEH | KTTA |
|---|---|---|
| Price | $0.27 | $1.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 221.4K | ★ 21.6M |
| Earning Date | 12-30-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,585,942.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.27 | $0.28 |
| 52 Week High | $50.08 | $3.85 |
Technical Indicators
Market Signals| Indicator | LXEH | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 27.92 | 60.63 |
| Support Level | $0.31 | $1.09 |
| Resistance Level | $0.33 | $1.23 |
| Average True Range (ATR) | 0.02 | 0.24 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 12.92 | 49.13 |
Price Performance
Historical ComparisonAbout LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).